The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Python

RUE CHARLES-BONNET 2, 1206 GENEVA, SWITZERLAND
Tel:
Work +41 22 702 15 15
Fax:
Fax +41 22 702 14 14
Email:
Web:
www.pplex.ch
Bern, Brussels, Geneva, Lausanne, Sion, Tehran and 2 more

Marc Iynedjian

Tel:
Work +41 22 702 15 15
Email:
Python

Position

Partner specializing in: * Corporate and M&A * Contracts * Real Estate * Arbitration.

Career

* Lecturer, LL.M. - International and European Economic and Commercial Law (University of Lausanne, School of Law) (2009 to date) * Partner with Python & Peter (2011 to date) * Associate with Python & Peter (2006 to 2010) * Visiting Attorney with Chadbourne & Parke LLP, New York (2005) * Trainee and then Associate with Bär & Karrer, Geneva (2000-2004) * Intern at the World Trade Organization (Legal Affairs Division), Geneva (2000) * Research and Teaching Assistant, Department of Comparative and European Law (Prof. M. Giovanoli), University of Lausanne (1998-2000).

Languages

* French * English * German.

Member

* Geneva Bar Association * Swiss Bar Association.

Education

*Geneva Bar (2002) *Columbia University School of Law (LL.M., 2005) * University of Lausanne (Doctorat en droit, 2002) * University of Lausanne (Licence en droit, 1998).


Switzerland

Commercial, corporate and M&A

Within: Commercial, corporate and M&A

The four-partner practice at Python handles corporate advice, reorganisation and transaction matters for domestic and international clients in the French-speaking part of Switzerland. Marc IynedjianChristophe de KalbermattenThomas Steinmann and Benjamin Humm are the key contacts.

[back to top]

Leading firms: French-speaking Switzerland

Within: Leading firms: French-speaking Switzerland

Python covers banking, corporate, real estate, tax and private client work. Nicolas de Gottrau, Marc IynedjianChristophe de KalbermattenHomayoon Arfazadeh and Etienne von Streng are the names to note.

[back to top]

Real estate and construction

Within: Real estate and construction

Mainly active in the French-speaking part of Switzerland, the real estate department at Python is considered to be 'very professional, client focused and reliable'. Key areas of expertise include residential and commercial transactions, construction projects, permit procedures and environmental issues, as well as financing, leasing, contractual and contentious matters. Marc Iynedjian, who 'has the capacity to translate the clients' need into contracts', advised Angelo Gordon and Westcore on the sale of an industrial building in Zurich to Akara Funds, and also assisted Realstone with the $130m share-deal purchase of an office building in Geneva. Clients also recommend the 'responsive and thoroughOlivier Klunge and Christophe de Kalbermatten.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Awarded "Law Firm of the Year - Switzerland" at the Citywealth Magic Circle Awards 201

    Bär & Karrer is pleased to announce that it has received the award “Law Firm of the Year - Switzerland” at the Citywealth Magic Circle Awards in London. This award recognizes Bär & Karrer as the Swiss law firm with the best private client team.
  • Bär & Karrer Advises Ashcroft on the Acquisition of Rüeger Holding

    Ashcroft Inc., headquartered in Stratford, CT, USA, a subsidiary of Tokyo Stock Exchange listed Nagano Keiki Co., Ltd, has announced the completion of the acquisition of Swiss-based Rüeger Holding SA (Rüeger) and Dutch-based STIKO Meetapparentenfabriek B.V. (Stiko), both manufacturers of specialty temperature and pressure measurement products, from their previous owners, Bernard and Jean-Marc Rüeger.
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.